Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I.

Garg AX, Clark WF, Haynes RB, House AA.

Kidney Int. 2002 Apr;61(4):1486-94.

3.

Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study.

Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD.

Kidney Int. 2002 Oct;62(4):1402-7.

4.

Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.

Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.

J Am Soc Nephrol. 2006 Feb;17(2):537-45. Epub 2005 Dec 28.

5.

Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States.

Muntner P, He J, Hamm L, Loria C, Whelton PK.

J Am Soc Nephrol. 2002 Mar;13(3):745-53.

6.

Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease.

Pasqualini L, Schillaci G, Pirro M, Vaudo G, Siepi D, Innocente S, Ciuffetti G, Mannarino E.

J Intern Med. 2007 Dec;262(6):668-77. Epub 2007 Oct 1.

7.

Retinopathy and CKD as predictors of all-cause and cardiovascular mortality: National Health and Nutrition Examination Survey (NHANES) 1988-1994.

Ricardo AC, Grunwald JE, Parvathaneni S, Goodin S, Ching A, Lash JP.

Am J Kidney Dis. 2014 Aug;64(2):198-203. doi: 10.1053/j.ajkd.2014.01.437. Epub 2014 Mar 19.

8.

Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III.

Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM.

Kidney Int. 2002 Jun;61(6):2165-75.

9.

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S.

Ann Intern Med. 2001 Apr 17;134(8):629-36.

PMID:
11304102
10.

Uric acid levels, kidney function, and cardiovascular mortality in US adults: National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2002.

Odden MC, Amadu AR, Smit E, Lo L, Peralta CA.

Am J Kidney Dis. 2014 Oct;64(4):550-7. doi: 10.1053/j.ajkd.2014.04.024. Epub 2014 Jun 4.

11.

The association of low selenium and renal insufficiency with coronary heart disease and all-cause mortality: NHANES III follow-up study.

Eaton CB, Abdul Baki AR, Waring ME, Roberts MB, Lu B.

Atherosclerosis. 2010 Oct;212(2):689-94. doi: 10.1016/j.atherosclerosis.2010.07.008. Epub 2010 Jul 17.

PMID:
20692659
12.

Association between moderate renal insufficiency and cardiovascular events in a general population: Tehran lipid and glucose study.

Hosseinpanah F, Barzin M, Golkashani HA, Nassiri AA, Sheikholeslami F, Azizi F.

BMC Nephrol. 2012 Jul 16;13:59. doi: 10.1186/1471-2369-13-59.

13.

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency.

Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D.

Kidney Int. 1999 Dec;56(6):2214-9.

14.

Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.

Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr.

J Am Geriatr Soc. 2009 Sep;57(9):1595-603. doi: 10.1111/j.1532-5415.2009.02359.x. Epub 2009 Jun 22.

PMID:
19549021
15.

Prospective association of periodontal disease with cardiovascular and all-cause mortality: NHANES III follow-up study.

Xu F, Lu B.

Atherosclerosis. 2011 Oct;218(2):536-42. doi: 10.1016/j.atherosclerosis.2011.07.091. Epub 2011 Jul 23.

PMID:
21831372
16.

Plasma fibrinogen associates independently with total and cardiovascular mortality among subjects with normal and reduced kidney function in the general population.

Stack AG, Donigiewicz U, Abdalla AA, Weiland A, Casserly LF, Cronin CJ, Nguyen HT, Hannigan A.

QJM. 2014 Sep;107(9):701-13. doi: 10.1093/qjmed/hcu057. Epub 2014 Mar 14.

PMID:
24633257
17.

Bone mineral density and mortality in women and men: the NHANES I epidemiologic follow-up study.

Mussolino ME, Madans JH, Gillum RF.

Ann Epidemiol. 2003 Nov;13(10):692-7.

PMID:
14599733
18.

Renal impairment and all-cause mortality in cardiovascular disease: effect modification by type 2 diabetes mellitus.

Selvarajah S, Uiterwaal CS, Haniff J, van der Graaf Y, Visseren FL, Bots ML; SMART study group.

Eur J Clin Invest. 2013 Feb;43(2):198-207. doi: 10.1111/eci.12035. Epub 2013 Jan 10.

PMID:
23301500
19.

Renal insufficiency increases mortality in acute coronary syndromes regardless of TIMI risk score.

Dudek D, Chyrchel B, Siudak Z, Depukat R, Chyrchel M, Dziewierz A, Mielecki W, Rakowski T, Rzeszutko Ł, Dubiel J.

Kardiol Pol. 2008 Jan;66(1):28-34; discussion 35-6.

20.

Association between serum homocysteine and markers of impaired kidney function in adults in the United States.

Francis ME, Eggers PW, Hostetter TH, Briggs JP.

Kidney Int. 2004 Jul;66(1):303-12.

Supplemental Content

Support Center